IGLJCOR18

Across TCGA pan-cancer cohorts, IGLJCOR18 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated IGLJCOR18 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGLJCOR18 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated IGLJCOR18 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, LIHC, and KIRP are the cancer types where IGLJCOR18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	0.806	0.634	.001	63	view →
LIHC	DFS	Quartile	All	0.203	0.368	.006	37	view →
KIRP	DFS	Tertile	All	0.336	0.663	.002	37	view →
SKCM	OS	Tertile	All	0.440	0.312	.009	36	view →
CESC	DFS	Tertile	IV	0.811	0.367	.020	36	view →
STAD	OS	Tertile	IV	0.711	0.244	.016	33	view →
KIRC	DFS	Tertile	All	0.629	0.829	<.001	24	view →
LUAD	DFS	Quartile	II,III,IV	0.703	0.499	.006	19	view →
LGG	OS	Tertile	All	0.195	0.528	.012	18	view →
READ	DFS	Tertile	IV	1.000	0.484	.031	12	view →
OV	DFS	Median	II,III,IV	0.601	0.509	.030	8	view →
DLBC	DFS	Median	IV	1.000	0.412	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

IGLJCOR18–HNSC (DFS)

Open the HNSC breakdown →